Colorectal cancer
Conditions
Interventions
The cancer group:Detection of ANK3 expression
Sponsors
The Second People's Hospital of Yibin
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18-80 years with pathologically confirmed colorectal adenocarcinoma; 2. TNM stage T1-3 n0-2 m0; 3. Preoperative chemoradiotherapy was not performed; 4. Volunteer to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Refuse to participate in or request to withdraw from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of ANK3 expression; | — |
Secondary
| Measure | Time frame |
|---|---|
| Prognostic indicators; | — |
Countries
China
Contacts
Public ContactZheng Tao
The Second People's Hospital of Yibin
Outcome results
None listed